Helsinki, Finland

Anne Kanerva

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Filamentous Fungi Biotechnology. Top assignees: Glykos Finland Oy, Unicrop Ltd, Tenboron Oy. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Kanerva. Retrieved from https://idiyas.com/inventor/anne-kanerva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 65.2

 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Itasalmi, FI (2006 - 2011)
  • Helsinki, FI (2002 - 2023)

Company Filing History:


Years Active: 2002-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Filamentous Fungi
Protease Deficiency
Glycoprotein Production
Anti-EGFR1 Antibody
Transgene Containment
Fucosylated Glycoproteins
Gene Segregation
Agrobacterium Transformation
23 patents (USPTO):Explore Patents

Title: Innovations by Anne Kanerva: A Focus on Filamentous Fungal Cells

Introduction

Anne Kanerva, based in Helsinki, Finland, is a prominent inventor known for her groundbreaking contributions to the field of biotechnology. With an impressive portfolio of 23 patents, her work primarily revolves around the innovative use of filamentous fungal cells.

Latest Patents

Among her latest patents, the two notable entries are titled "Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof." This disclosure relates to compositions and methods that are essential for producing heterologous proteins in filamentous fungal cells. This advancement has significant implications for various industrial applications, particularly in the pharmaceutical and agricultural sectors.

Career Highlights

Anne has worked with prominent companies, including Glykos Finland Oy and Unicrop Ltd. Her expertise in biotechnology and patent development has greatly influenced the direction of research and product development in these organizations, fostering innovation and enhancing their competitive edge in the market.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues, including Anne Huuskonen and Markku Saloheimo. These collaborations have enriched her research endeavors, enabling her to share knowledge and expertise, and ultimately driving forward the advancements in their respective fields.

Conclusion

In conclusion, Anne Kanerva stands out as an influential inventor whose contributions to the field of filamentous fungal cells continue to shape the landscape of biotechnology. Her impressive patent portfolio and collaborative spirit underscore her commitment to innovation and discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…